Abstract
Background A 30-year-old woman with suspected multiple endocrine neoplasia type 1 (MEN1) was referred to our center in 2001 with primary hyperparathyroidism caused by a multiglandular parathyroid adenoma. The patient also had hyperprolactinemia caused by an anterior pituitary macroadenoma. The patient underwent a parathyroidectomy with autotransplantation of parathyroid fragments into the nondominant forearm, resulting in resolution of the primary hyperparathyroidism. MEN1 was confirmed by analysis of the MEN1 gene, which revealed a 1555insG frameshift mutation. In 2006 serum calcium and parathyroid hormone (PTH) levels were again found to be high.
Investigations After parathyroidectomy in 2001, the patient underwent regular measurements of PTH levels from both forearms, of serum calcium, prolactin and phosphate levels, and of urinary calcium and phosphate levels. When serum calcium and PTH levels were found to be elevated in 2006, circulating PTH levels were similar in both forearms. Ultrasound scan and technetium-99m-labeled hexakis-2-methoxyisobutylisonitrile (99mTc MIBI) scintigraphy evidenced a metabolically active parathyroid nodule in the neck.
Diagnosis Local recurrence of a parathyroid adenoma associated with MEN1.
Management Because the patient refused a further operation, we decided to initiate pharmacological treatment with cinacalcet. After 1 month of therapy, serum calcium and PTH levels returned to normal. The patient has now been closely monitored for 1 year. During this time calcium and PTH levels remained normal, morphologically the parathyroid nodular lesion remained unchanged and cinacalcet was well tolerated without the occurrence of adverse events. Cinacalcet could represent an important pharmacological intervention in MEN1-associated primary hyperparathyroidism before surgery and in postsurgical recurrences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Morelli A et al. (2000) MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 142: 131–137
Tonelli F et al. (2007) Is total parathyroidectomy the treatment of choice for hyperparathyroidism in Multiple Endocrine Neoplasia Type 1. Ann Surg 246: 1075–1082
Allo M and Thompson NW (1982) Familial hyperparathyroidism caused by solitary adenomas. World J Surg 92: 486–490
Kollars J et al. (2005) Primary hyperparathyroidism in pediatric patients. Pediatrics 115: 974–980
Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671
Falchetti A et al. (online 31 August 2005) Multiple Endocrine Neoplasia Type 1. [http://www.genetests.org/servlet/access?db=geneclinics&site=gt&id= 8888891&key=OGoY5yiCujWmU&gry=&fcn=y&fw=OAYb&filename=/profiles/ men1/index.html] (accessed 5/3/08)
Elaraj DM et al. (2003) Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 134: 858–864
Carling T and Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257: 27–37
Nemeth EF et al. (1998) Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95: 4040–4045
Barman Balfour JA and Scott LJ (2005) Cinacalcet hydrochloride. Drugs 65: 271–281
Joy MS et al. (2004) Calcimimetics and the treatment of primary and secondary hyperparathyroidism. Ann Pharmacother 38: 1871–1880
Peacock M et al. (2005) Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90: 135–141
Shoback DM et al. (2003) The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 5644–5649
Meko JB and Norton JA (1995) Management of patients with Zollinger–Ellison syndrome. Ann Rev Med 46: 395–411
Brown EM et al. (1993) Cloning and characterization of an extracellular Ca2-sensing receptor from bovine parathyroid. Nature 366: 575–580
Ray JM et al. (1997) Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest 99: 2328–2333
Darè E et al. (1998) Characterization of the phosphatidylinositol-specific phospholipase C isozymes present in the bovine parathyroid and in human kidney HEK293 cells stably transfected with the human parathyroid Ca2+-sensing receptor. J Mol Endocrinol 21: 7–17
Burgess JR et al. (1999) Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg 134: 1119–1123
Lairmore TC et al. (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239: 637–645
Acknowledgements
ML Brandi has been supported by the Fondazione Cassa di Risparmio di Firenze for this work. The Regional Center for Hereditary Endocrine Tumors, directed by ML Brandi, is supported by the Tuscany Region.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Falchetti, A., Cilotti, A., Vagelli, L. et al. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Rev Endocrinol 4, 351–357 (2008). https://doi.org/10.1038/ncpendmet0816
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0816
This article is cited by
-
Cystic parathyroid glands in MEN1: A rare entity?
Familial Cancer (2017)
-
Care for patients with multiple endocrine neoplasia type 1: the current evidence base
Familial Cancer (2011)
-
Erratum: A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet
Nature Clinical Practice Endocrinology & Metabolism (2008)